1	Soluble	soluble	_	_	_	_	_	_	_
2	tumor	tumor	_	_	_	_	_	_	_
3	necrosis	necrosis	_	_	_	_	_	_	_
4	factor	factor	_	_	_	_	_	_	_
5	receptors	receptor	_	_	_	_	_	_	_
6	inhibit	inhibit	_	_	_	_	_	_	_
7	phorbol	phorbol	_	_	_	_	_	_	_
8	myristate	myristate	_	_	_	_	_	_	_
9	acetate	acetate	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	cytokine-induced	cytokine-induced	_	_	_	_	_	_	_
12	HIV-1	HIV-1	_	_	_	_	_	_	_
13	expression	expression	_	_	_	_	_	_	_
14	chronically	chronically	_	_	_	_	_	_	_
15	infected	infected	_	_	_	_	_	_	_
16	U1	u1	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Recombinant	recombinant	_	_	_	_	_	_	_
2	human	human	_	_	_	_	_	_	_
3	tumor	tumor	_	_	_	_	_	_	_
4	necrosis	necrosis	_	_	_	_	_	_	_
5	factor	factor	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	TNF	TNF	_	_	_	_	_	_	_
8	)	)	_	_	_	_	_	_	_
9	binding	binding	_	_	_	_	_	_	_
10	protein-1	protein-1	_	_	_	_	_	_	_
11	(	(	_	_	_	_	_	_	_
12	r-h	r-h	_	_	_	_	_	_	_
13	TBP-1	tbp-1	_	_	_	_	_	_	_
14	)	)	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	recombinant	recombinant	_	_	_	_	_	_	_
17	human	human	_	_	_	_	_	_	_
18	soluble	soluble	_	_	_	_	_	_	_
19	dimeric	dimeric	_	_	_	_	_	_	_
20	TNF	tnf	_	_	_	_	_	_	_
21	receptor	receptor	_	_	_	_	_	_	_
22	(	(	_	_	_	_	_	_	_
23	rhu	rhu	_	_	_	_	_	_	_
24	TNFR:Fc	TNFR:Fc	_	_	_	_	_	_	_
25	)	)	_	_	_	_	_	_	_
26	were	be	_	_	_	_	_	_	_
27	used	use	_	_	_	_	_	_	_
28	to	to	_	_	_	_	_	_	_
29	determine	determine	_	_	_	_	_	_	_
30	the	the	_	_	_	_	_	_	_
31	relative	relative	_	_	_	_	_	_	_
32	contributions	contribution	_	_	_	_	_	_	_
33	of	of	_	_	_	_	_	_	_
34	TNF	TNF	_	_	_	_	_	_	_
35	to	to	_	_	_	_	_	_	_
36	phorbol	phorbol	_	_	_	_	_	_	_
37	myristate	myristate	_	_	_	_	_	_	_
38	acetate	acetate	_	_	_	_	_	_	_
39	(	(	_	_	_	_	_	_	_
40	PMA	PMA	_	_	_	_	_	_	_
41	)	)	_	_	_	_	_	_	_
42	and	and	_	_	_	_	_	_	_
43	cytokine-induced	cytokine-induced	_	_	_	_	_	_	_
44	human	human	_	_	_	_	_	_	_
45	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
46	virus	virus	_	_	_	_	_	_	_
47	type	type	_	_	_	_	_	_	_
48	1	1	_	_	_	_	_	_	_
49	(	(	_	_	_	_	_	_	_
50	HIV-1	HIV-1	_	_	_	_	_	_	_
51	)	)	_	_	_	_	_	_	_
52	replication	replication	_	_	_	_	_	_	_
53	in	in	_	_	_	_	_	_	_
54	chronically	chronically	_	_	_	_	_	_	_
55	infected	infected	_	_	_	_	_	_	_
56	cell	cell	_	_	_	_	_	_	_
57	lines	line	_	_	_	_	_	_	_
58	.	.	_	_	_	_	_	_	_

1	Treatment	Treatment	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	HIV-1-infected	hiv-1-infected	_	_	_	_	_	_	_
4	promonocytic	promonocytic	_	_	_	_	_	_	_
5	U1	u1	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	with	with	_	_	_	_	_	_	_
8	r-h-TBP-1	r-h-tbp-1	_	_	_	_	_	_	_
9	or	or	_	_	_	_	_	_	_
10	rhu	rhu	_	_	_	_	_	_	_
11	TNFR:Fc	TNFR:Fc	_	_	_	_	_	_	_
12	reduced	reduce	_	_	_	_	_	_	_
13	PMA-induced	pma-induced	_	_	_	_	_	_	_
14	HIV-1	HIV-1	_	_	_	_	_	_	_
15	p24	p24	_	_	_	_	_	_	_
16	antigen	antigen	_	_	_	_	_	_	_
17	production	production	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	a	a	_	_	_	_	_	_	_
20	concentration-dependent	concentration-dependent	_	_	_	_	_	_	_
21	manner	manner	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	with	with	_	_	_	_	_	_	_
24	a	a	_	_	_	_	_	_	_
25	maximal	maximal	_	_	_	_	_	_	_
26	inhibition	inhibition	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	approximately	approximately	_	_	_	_	_	_	_
29	90	90	_	_	_	_	_	_	_
30	%	%	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	Maximal	maximal	_	_	_	_	_	_	_
2	inhibition	inhibition	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	p24	p24	_	_	_	_	_	_	_
5	antigen	antigen	_	_	_	_	_	_	_
6	production	production	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	T-lymphocytic	t-lymphocytic	_	_	_	_	_	_	_
9	ACH-2	ach-2	_	_	_	_	_	_	_
10	cells	cell	_	_	_	_	_	_	_
11	was	be	_	_	_	_	_	_	_
12	47	47	_	_	_	_	_	_	_
13	%	%	_	_	_	_	_	_	_
14	with	with	_	_	_	_	_	_	_
15	r-hTBP-1	r-htbp-1	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	42	42	_	_	_	_	_	_	_
18	%	%	_	_	_	_	_	_	_
19	with	with	_	_	_	_	_	_	_
20	rhu	rhu	_	_	_	_	_	_	_
21	TNFR:Fc.	TNFR:Fc.	_	_	_	_	_	_	_
22	r-hTBP-1	r-htbp-1	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	rhu	rhu	_	_	_	_	_	_	_
25	TNFR:Fc	TNFR:Fc	_	_	_	_	_	_	_
26	also	also	_	_	_	_	_	_	_
27	decreased	decrease	_	_	_	_	_	_	_
28	p24	p24	_	_	_	_	_	_	_
29	antigen	antigen	_	_	_	_	_	_	_
30	synthesized	synthesize	_	_	_	_	_	_	_
31	by	by	_	_	_	_	_	_	_
32	U1	u1	_	_	_	_	_	_	_
33	cells	cell	_	_	_	_	_	_	_
34	in	in	_	_	_	_	_	_	_
35	response	response	_	_	_	_	_	_	_
36	to	to	_	_	_	_	_	_	_
37	other	other	_	_	_	_	_	_	_
38	stimuli	stimulus	_	_	_	_	_	_	_
39	,	,	_	_	_	_	_	_	_
40	including	include	_	_	_	_	_	_	_
41	phytohemagglutinin	phytohemagglutinin	_	_	_	_	_	_	_
42	(	(	_	_	_	_	_	_	_
43	PHA)-induced	pha)-induced	_	_	_	_	_	_	_
44	supernatant	supernatant	_	_	_	_	_	_	_
45	,	,	_	_	_	_	_	_	_
46	granulocyte-macrophage	granulocyte-macrophage	_	_	_	_	_	_	_
47	colony-stimulating	colony-stimulating	_	_	_	_	_	_	_
48	factor	factor	_	_	_	_	_	_	_
49	,	,	_	_	_	_	_	_	_
50	interleukin-6	interleukin-6	_	_	_	_	_	_	_
51	,	,	_	_	_	_	_	_	_
52	and	and	_	_	_	_	_	_	_
53	TNF	TNF	_	_	_	_	_	_	_
54	.	.	_	_	_	_	_	_	_

1	Addition	addition	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	r-hTBP-1	r-htbp-1	_	_	_	_	_	_	_
4	to	to	_	_	_	_	_	_	_
5	U1	u1	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	during	during	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	last	last	_	_	_	_	_	_	_
10	4	4	_	_	_	_	_	_	_
11	h	h	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	a	a	_	_	_	_	_	_	_
14	24	24	_	_	_	_	_	_	_
15	h	h	_	_	_	_	_	_	_
16	incubation	incubation	_	_	_	_	_	_	_
17	with	with	_	_	_	_	_	_	_
18	PMA	PMA	_	_	_	_	_	_	_
19	still	still	_	_	_	_	_	_	_
20	inhibited	inhibit	_	_	_	_	_	_	_
21	p24	p24	_	_	_	_	_	_	_
22	antigen	antigen	_	_	_	_	_	_	_
23	production	production	_	_	_	_	_	_	_
24	by	by	_	_	_	_	_	_	_
25	15	15	_	_	_	_	_	_	_
26	%	%	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	U1	u1	_	_	_	_	_	_	_
2	cells	cell	_	_	_	_	_	_	_
3	stimulated	stimulate	_	_	_	_	_	_	_
4	with	with	_	_	_	_	_	_	_
5	10(-7)	10(-7)	_	_	_	_	_	_	_
6	M	M	_	_	_	_	_	_	_
7	PMA	PMA	_	_	_	_	_	_	_
8	released	release	_	_	_	_	_	_	_
9	approximately	approximately	_	_	_	_	_	_	_
10	1	1	_	_	_	_	_	_	_
11	ng/ml	ng/ml	_	_	_	_	_	_	_
12	endogenous	endogenous	_	_	_	_	_	_	_
13	TBP-1	tbp-1	_	_	_	_	_	_	_
14	with	with	_	_	_	_	_	_	_
15	an	an	_	_	_	_	_	_	_
16	initial	initial	_	_	_	_	_	_	_
17	peak	peak	_	_	_	_	_	_	_
18	observed	observe	_	_	_	_	_	_	_
19	at	at	_	_	_	_	_	_	_
20	1	1	_	_	_	_	_	_	_
21	h	h	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	a	a	_	_	_	_	_	_	_
24	second	second	_	_	_	_	_	_	_
25	peak	peak	_	_	_	_	_	_	_
26	at	at	_	_	_	_	_	_	_
27	24	24	_	_	_	_	_	_	_
28	h	h	_	_	_	_	_	_	_
29	after	after	_	_	_	_	_	_	_
30	PMA	PMA	_	_	_	_	_	_	_
31	stimulation.	stimulation.	_	_	_	_	_	_	_
32	r-hTBP-1	r-htbp-1	_	_	_	_	_	_	_
33	also	also	_	_	_	_	_	_	_
34	partially	partially	_	_	_	_	_	_	_
35	reversed	reverse	_	_	_	_	_	_	_
36	inhibition	inhibition	_	_	_	_	_	_	_
37	of	of	_	_	_	_	_	_	_
38	U1	u1	_	_	_	_	_	_	_
39	cellular	cellular	_	_	_	_	_	_	_
40	proliferation	proliferation	_	_	_	_	_	_	_
41	caused	cause	_	_	_	_	_	_	_
42	by	by	_	_	_	_	_	_	_
43	PMA	PMA	_	_	_	_	_	_	_
44	.	.	_	_	_	_	_	_	_

1	Both	both	_	_	_	_	_	_	_
2	r-hTBP-1	r-htbp-1	_	_	_	_	_	_	_
3	and	and	_	_	_	_	_	_	_
4	rhu	rhu	_	_	_	_	_	_	_
5	TNFR:Fc	TNFR:Fc	_	_	_	_	_	_	_
6	blocked	block	_	_	_	_	_	_	_
7	PMA	PMA	_	_	_	_	_	_	_
8	induction	induction	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	nuclear	nuclear	_	_	_	_	_	_	_
11	factor	factor	_	_	_	_	_	_	_
12	(	(	_	_	_	_	_	_	_
13	NK)-	nk)-	_	_	_	_	_	_	_
14	kappa	kappa	_	_	_	_	_	_	_
15	B	B	_	_	_	_	_	_	_
16	DNA-binding	dna-binding	_	_	_	_	_	_	_
17	activity	activity	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	U1	u1	_	_	_	_	_	_	_
20	cells	cell	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	association	association	_	_	_	_	_	_	_
23	with	with	_	_	_	_	_	_	_
24	decreases	decrease	_	_	_	_	_	_	_
25	in	in	_	_	_	_	_	_	_
26	HIV-1	HIV-1	_	_	_	_	_	_	_
27	replication	replication	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	conclude	conclude	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	soluble	soluble	_	_	_	_	_	_	_
5	TNF	tnf	_	_	_	_	_	_	_
6	receptors	receptor	_	_	_	_	_	_	_
7	can	can	_	_	_	_	_	_	_
8	inhibit	inhibit	_	_	_	_	_	_	_
9	stimuli-induced	stimuli-induced	_	_	_	_	_	_	_
10	HIV-1	HIV-1	_	_	_	_	_	_	_
11	expression	expression	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	NK-	nk-	_	_	_	_	_	_	_
14	kappa	kappa	_	_	_	_	_	_	_
15	B	B	_	_	_	_	_	_	_
16	DNA-binding	dna-binding	_	_	_	_	_	_	_
17	activity	activity	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	chronically	chronically	_	_	_	_	_	_	_
20	infected	infected	_	_	_	_	_	_	_
21	U1	u1	_	_	_	_	_	_	_
22	cells	cell	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

